{"id":"NCT01681069","sponsor":"InQpharm Group","briefTitle":"Efficacy and Safety of IQP-VV-102 in Weight Management","officialTitle":"Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2012-09-07","resultsPosted":"2015-11-06","lastUpdate":"2015-11-06"},"enrollment":120,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity","Overweight"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"IQP-VV-102","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"IQP-VV-102","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Subjects are randomized to either IQP-VV-102 or a matching placebo. Over 12 weeks, the subjects' body weight, body fat and safety parameters are monitored","primaryOutcome":{"measure":"Change in Body Weight at End of Study Compared to Baseline","timeFrame":"12 weeks","effectByArm":[{"arm":"IQP-VV-102","deltaMin":3.29,"sd":2.3},{"arm":"Placebo","deltaMin":0.83,"sd":2}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":["26074990"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":["Respiratory infections","Headache","Urinary Tract Infection","Vomitting and diarhoea","Hypothyrodism"]}}